Differentiating biologics to prevent psoriatic arthritis in patients with psoriasis - Authors' reply.

Competing Interests: MP receives research funding from AbbVie and AstraZeneca and consulting fees from Novartis. JL received a research grant from Pfizer. KG receives consulting fees from AbbVie, Almiral, Amgen, Bristol Myers Squibb, Dermavant, Dermira, Eli Lilly, Janssen, Kyowa Hakko Kirin, Leo, Novartis, Pfizer, Sun, UCB, and Union; payment or honoraria for speakers bureaus from Bristol Myers Squibb; and payment or honoraria for manuscript writing support from UCB, Bristol Myers Squibb, and Janssen. SS declares no competing interests.